Blake Borgeson sold $588K of Recursion Pharmaceuticals (RXRX)

Executed Mar 3, disclosed Mar 4, 1 day later.

Value, as filed

$588K

170,000 sh × $3.46

Executed

Mar 3

the trade date, as filed

Disclosed

Mar 4

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Blake Borgeson Director profile →

Blake Borgeson (Director) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales, 1 filed past the two-business-day deadline), most often in Recursion Pharmaceuticals, Inc. (RXRX). The largest single filing was $961K of RXRX (220,000 sh × $4.37, as filed), executed Dec 2 2025.

The name

RXRX

Recursion Pharmaceuticals, Inc. RXRX · Healthcare · 38 filings in 24 months ticker →

Healthcare · Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating techn…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Blake Borgeson in RXRX

RXRXSALE Recursion Pharmaceuticals, Inc. $100K
30,000 sh × $3.34
Exec Sep 1
Filed Sep 2 · 6:01 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. $158K
40,000 sh × $3.96
Exec Jul 7
Filed Jul 9 · 6:04 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. $110K
30,000 sh × $3.68
Exec Jun 2
Filed Jun 4 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. $106K
30,000 sh × $3.52
Exec May 5
Filed May 7 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. $924K
220,000 sh × $4.20
Exec Feb 3
Filed Feb 6 · 5:30 PM ET † RXRXSALE Recursion Pharmaceuticals, Inc. $959K
220,000 sh × $4.36
Exec Jan 6
Filed Jan 8 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. $961K
220,000 sh × $4.37
Exec Dec 2 2025
Filed Dec 4 2025 · 5:30 PM ET